Jupiter Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Jupiter Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$923K	Buy	+8,366	New	+$925K	0.01%	292

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jupiter Investment Management's JAZZ Position: Q2 2020 in Review

Jupiter Investment Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2020: 8,366 shares worth $923K. The stake represents 0.01% of the portfolio and ranks #292 among its holdings.

384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

Jupiter Investment Management held 8,366 shares of Jazz Pharmaceuticals worth $923K as of Q2 2020.
Jazz Pharmaceuticals was a new Jupiter Investment Management position in Q2 2020.
Jazz Pharmaceuticals made up 0.01% of Jupiter Investment Management's portfolio in Q2 2020, its #292 holding.
384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.